An Anti-Metabolic Prodromal Phenotype in Endometriosis

preprint OA: green CC0
AI-generated summary by qwen3.7-flash, 2026-09-19

A prospective UK Biobank study of 273,043 women identified an anti-metabolic prodromal phenotype in endometriosis characterized by lower metabolic dysfunction, lower pulse pressure, and lean body composition.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-09-19 · read from full text

This prospective cohort study analyzed data from 273,043 female UK Biobank participants to identify prodromal biomarkers for incident endometriosis using a four-stage machine learning pipeline. The researchers evaluated 233 candidate features to characterize the metabolic profile of women who later developed the condition compared to those who did not. Key findings revealed an anti-metabolic phenotype in endometriosis, characterized by lower metabolic dysfunction, reduced pulse pressure, and lean body composition, which contrasts sharply with the pro-metabolic signatures typical of cardiovascular, renal, or hepatic diseases. This paper is centrally about endometriosis — specifically characterizing its distinct metabolic prodromal phenotype through large-scale epidemiological analysis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis exhibits an anti-metabolic prodromal phenotype: lower metabolic dysfunction, lower pulse pressure, and a lean body composition, in sharp contrast to the pro-metabolic signatures of cardiovascular, renal, and hepatic disease. Endometriosis affects approximately 10% of reproductive- age women and is associated with chronic pelvic pain, infertility, and reduced quality of life. Epidemiological studies have reported inverse associations between endometriosis and cardiovascular risk factors, but no study has characterized a comprehensive prodromal biomarker signature or framed the condition within a multi-disease prediction architecture. This was a prospective cohort study of 273,043 female UK Biobank participants (enrollment 2006–2010; median follow-up 14.1 years). Incident endometriosis was identified from Hospital Episode Statistics (ICD-10 N80). A four- stage machine learning pipeline (literature priors, univariate screening, gradient-boosted feature selection, logistic regression) using 233 candidate features was applied with 5- fold cross-validation.
Full text 1,573 characters · extracted from oa-doi-fallback · click to expand
An Anti-Metabolic Prodromal Phenotype in Endometriosis Authors/Creators - 1. Center for Molecular Cardiology, University of Zurich - 2. Center for Complexity Sciences, National University of Mexico - 3. Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Description Endometriosis exhibits an anti-metabolic prodromal phenotype: lower metabolic dysfunction, lower pulse pressure, and a lean body composition, in sharp contrast to the pro-metabolic signatures of cardiovascular, renal, and hepatic disease. Endometriosis affects approximately 10% of reproductive- age women and is associated with chronic pelvic pain, infertility, and reduced quality of life. Epidemiological studies have reported inverse associations between endometriosis and cardiovascular risk factors, but no study has characterized a comprehensive prodromal biomarker signature or framed the condition within a multi-disease prediction architecture. This was a prospective cohort study of 273,043 female UK Biobank participants (enrollment 2006–2010; median follow-up 14.1 years). Incident endometriosis was identified from Hospital Episode Statistics (ICD-10 N80). A four- stage machine learning pipeline (literature priors, univariate screening, gradient-boosted feature selection, logistic regression) using 233 candidate features was applied with 5- fold cross-validation. Files An Anti-Metabolic Prodromal Phenotype in Endometriosis [draft v6].pdf Files (742.7 kB) | Name | Size | Download all | |---|---|---| | md5:acf1c94eb6b00620838c26fd637f7b6f | 742.7 kB | Preview Download |

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-09-24T06:01:16.130947+00:00
License: CC0 · commercial use OK